Randomized Double Blind Placebo-Controlled Parallel Group, MultiCenter Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema following Larg
Clinical Trial Grant
Administered By
Neurology, Neurocritical Care
Awarded By
Biogen, Inc.
Start Date
July 26, 2018
End Date
January 29, 2021
Administered By
Neurology, Neurocritical Care
Awarded By
Biogen, Inc.
Start Date
July 26, 2018
End Date
January 29, 2021